Predictions
Curis Inc.
Start price
Target price
Perf. (%)
€6.35
13.12.20
13.12.20
-
13.12.21
13.12.21
37.01%
16.02.21
16.02.21
Below average Marketposition
Probably not worthwhile Investment
Significant cyclical dependencies
Little known brand
Lexicon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.66
13.12.20
13.12.20
-
13.12.21
13.12.21
143.95%
16.02.21
16.02.21
Probably not worthwhile Investment
Significant cyclical dependencies
Inovio Pharma
Start price
Target price
Perf. (%)
€9.35
10.12.20
10.12.20
€7.00
10.12.21
10.12.21
20.86%
20.02.21
20.02.21
Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Lexicon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.56
08.12.20
08.12.20
-
6.64%
10.12.20
10.12.20
Risky Investment
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€5.51
07.12.20
07.12.20
€25.00
07.12.21
07.12.21
93.92%
08.12.21
08.12.21
Could be very worthwhile Investment >20% year
Trevena Inc.
Start price
Target price
Perf. (%)
€49.08
04.12.20
04.12.20
€55.00
28.04.21
28.04.21
23.84%
09.02.21
09.02.21
Could be very worthwhile Investment >20% year
Corbus Pharmaceuticals Holding Inc.
Start price
Target price
Perf. (%)
€46.50
01.12.20
01.12.20
€90.00
01.12.21
01.12.21
-27.97%
14.12.20
14.12.20
Could be worthwhile Investment >10% per year
Very bad culture
No uniques
Below average Management
Genmark Diagnostics
Start price
Target price
Perf. (%)
€11.10
30.11.20
30.11.20
€14.00
30.11.21
30.11.21
-7.21%
14.12.20
14.12.20
Could be worthwhile Investment >10% per year
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€13.50
30.11.20
30.11.20
€15.00
30.11.21
30.11.21
31.85%
14.12.20
14.12.20
Could be worthwhile Investment >10% per year
Cutera Inc.
Start price
Target price
Perf. (%)
€21.00
30.11.20
30.11.20
€25.00
30.11.21
30.11.21
-15.71%
14.12.20
14.12.20
Could be worthwhile Investment >10% per year
CHF Solutions Inc
Start price
Target price
Perf. (%)
-
30.11.20
30.11.20
€7.00
30.11.21
30.11.21
-
14.12.20
14.12.20
Could be very worthwhile Investment >20% year
Inovio Pharma
Start price
Target price
Perf. (%)
€10.60
29.11.20
29.11.20
€12.00
29.11.21
29.11.21
-11.79%
10.12.20
10.12.20
Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Revance Therapeutics Inc.
Start price
Target price
Perf. (%)
€19.50
28.11.20
28.11.20
€23.00
28.11.21
28.11.21
-36.41%
01.11.21
01.11.21
Could be worthwhile Investment >10% per year
Inovio Pharma
Start price
Target price
Perf. (%)
€8.95
21.11.20
21.11.20
-
21.11.21
21.11.21
28.49%
10.02.21
10.02.21
Could be worthwhile Investment >10% per year
High risks for its business
Dependend from few customers or products
Genmark Diagnostics
Start price
Target price
Perf. (%)
€11.50
16.11.20
16.11.20
€13.00
16.11.21
16.11.21
-3.48%
30.11.20
30.11.20
Could be worthwhile Investment >10% per year
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€13.20
16.11.20
16.11.20
€15.00
16.11.21
16.11.21
2.27%
30.11.20
30.11.20
Could be worthwhile Investment >10% per year
Cutera Inc.
Start price
Target price
Perf. (%)
€18.10
16.11.20
16.11.20
€20.00
16.11.21
16.11.21
16.02%
30.11.20
30.11.20
Could be worthwhile Investment >10% per year
CHF Solutions Inc
Start price
Target price
Perf. (%)
-
16.11.20
16.11.20
€7.00
16.11.21
16.11.21
-
30.11.20
30.11.20
Could be very worthwhile Investment >20% year
Bellicum Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.30
07.11.20
07.11.20
-
07.11.21
07.11.21
15.65%
15.07.21
15.07.21
Probably not worthwhile Investment
Misonix Inc.
Start price
Target price
Perf. (%)
€9.55
02.11.20
02.11.20
€11.00
04.11.21
04.11.21
4.19%
16.11.20
16.11.20
Could be worthwhile Investment >10% per year
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€11.40
02.11.20
02.11.20
€13.00
04.11.21
04.11.21
15.79%
16.11.20
16.11.20
Could be worthwhile Investment >10% per year
Genmark Diagnostics
Start price
Target price
Perf. (%)
€10.90
02.11.20
02.11.20
€13.00
04.11.21
04.11.21
5.50%
16.11.20
16.11.20
Could be worthwhile Investment >10% per year
CHF Solutions Inc
Start price
Target price
Perf. (%)
-
02.11.20
02.11.20
€8.00
04.11.21
04.11.21
-
16.11.20
16.11.20
Could be very worthwhile Investment >20% year
Sorrento Therapeutics Inc.
Start price
Target price
Perf. (%)
€6.15
02.11.20
02.11.20
€13.00
04.11.21
04.11.21
-4.96%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Top 10 in its market
Leading role in innovation